Skip to site menu
Skip to page content
PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Pricing and Market Access
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Buy Reports
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Control and confidence in clinical data management
Connecting healthcare tech with the life sciences industry
Optimizing Cell & Gene Therapy Processes
Collaboration and Expertise in Contract Analytical Chemistry
A new generation of CDMO services
Accelerating Biopharmaceutical Innovation
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
The next chapter of clinical trial services
Putting quality first in the pharma supply chain
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
FDA layoffs and priority review programme’s lapse disrupt rare disease pipeline
The GLP-1 drug shortage is over. What’s next for the compounders?
Can AI replace medical writers? Experts say not immediately
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Pricing and Market Access
Latest
Merck KGaA nears $3.5bn deal for SpringWorks
FDA free to pursue semaglutide compounders after latest court ruling
FDA approves Akeso’s monoclonal antibody for nasopharyngeal carcinoma
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Foreign Direct Investment
Latest
Caribou cuts pipeline and workforce to focus on lead CAR-T programmes
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Immedica to buy Marinus Pharmaceuticals for $151m
Private equity deals in pharmaceutical in Canada remained flat in Q3 2024
Q3 2024 update: artificial intelligence related private equity activity in the pharmaceutical industry
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
Challenges in filling for alum drug products: What does a CDMO need to successfully fill alum drug products?
FSO vs FSP: One CRO highlights key considerations for your decision
Spotlight on Hepatitis B: New report examines the disease’s clinical trial landscape in 2025
Events
Buy Reports
Newsletters
PT
All articles by Michael Jones
Michael Jones
View more
